ACBP/DBI neutralization for the experimental treatment of fatty liver disease

Omar Motiño; Flavia Lambertucci; Adrien Joseph; Sylvère Durand; Gerasimos Anagnostopoulos; Sijing Li; Vincent Carbonnier; Uxía Nogueira-Recalde; Léa Montégut; Hui Chen; Fanny Aprahamian; Nitharsshini Nirmalathasan; Maria Chiara Maiuri; Federico Pietrocola; Dominique Valla; Cédric Laouénan; Jean‐François Gautier; Laurent Castéra; Laurent Castéra; Anaïs Vallet‐Pichard; Tiphaine Vidal-Trécan; Pauline Manchon; Valérie Paradis; Dominique Roulot; Christian Boîtard; Benoît Terris; H. Bihan; Jean‐Baptiste Julla; Thierry Poynard; Angélique Bzrustowski; Étienne Larger; S. Czernichow; Stanislas Pol; Pierre Bédossa; Christophe Junot; Nathalie de Préville; Isabelle Durand‐Zaleski; Pierre‐Emmanuel Rautou; Bernard E. Van Beers; Marco Dioguardi Burgio; Valérie Vilgrain; Jean-Michel Corréas; Philippe Garteiser; Jean-Pierre Riveline; Mark Ibberson; Isabelle Martins; Guido Guido Kroemer

doi:10.1038/s41418-024-01410-6

Related publications

Article2025

ACBP/DBI neutralization for the prevention and treatment of malignant and non-malignant liver diseases

Sijing Li, Flavia Lambertucci, Léa Montégut, Isabel Martins, Jonathan Pol, Mauro Piacentini, Maria Chiara Maiuri, Guido Guido Kroemer

Article2026

Neutralization of DBI/ACBP for the prevention of ciliopathy-associated obesity

Yaiza Corral Nieto, Guido Guido Kroemer, José Manuel Bravo-San Pedro

Article2020

Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects

Valentina Sica, Isabelle Martins, Omar Motiño, José Manuel Bravo‐San Pedro, Guido Guido Kroemer

Article2025

Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis

Uxía Nogueira-Recalde, Flavia Lambertucci, Léa Montégut, Omar Motiño, Hui Chen, Sylvie Lachkar, Gerasimos Anagnostopoulos, Gautier Stoll, S N Li, Vincent Carbonier, Elkin Díaz, Francisco J. Blanco, Geert van Tetering, Mark de Boer, Maria Chiara Maiuri, B. Caramés, Isabelle Martins, Guido Guido Kroemer

Article2025

Pathological aging is alleviated by neutralization of the autophagy-repressive tissue hormone DBI/ACBP

Léa Montégut, Flavia Lambertucci, Lucas Moledo-Nodar, Isabel Martins, Alejandro Lucía, Clea Bárcena, Guido Guido Kroemer

ACBP/DBI neutralization for the experimental treatment of fatty liver disease

Discussion(0)

Related publications

ACBP/DBI neutralization for the prevention and treatment of malignant and non-malignant liver diseases

Neutralization of DBI/ACBP for the prevention of ciliopathy-associated obesity

Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects

Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis

Pathological aging is alleviated by neutralization of the autophagy-repressive tissue hormone DBI/ACBP